Select Page

Researchmoz added Most up-to-date research on “China In-Vitro Diagnostics (IVD) Market, Forecast, Companies Analysis, Registration Rules” to its huge collection of research reports.

China In-vitro diagnostics market is expected to be triple its market size by the end of 2022 from its market size in 2016. China In-Vitro Diagnostics sector is expected to grow with a double digit CAGR of 19.01% in future. With such a huge growth rate China is poised to become the world’s largest In–vitro Diagnostics (IVD) Market in the next few years for both domestic and foreign IVD products. The In–Vitro Diagnostics (IVD) Market in China has been growing rapidly over the past few years and is expected to grow steadily in the coming future, with major growth potential in segments such as contagious disease testing, chronic disease testing and diagnosis in early stages of disease.

Interpret a Competitive Outlook Analysis with Sample Report:

China In-Vitro Diagnostics (IVD) – Segment Analysis

Immunoassay has the highest market share in China IVD market, but after 2018 its market share will decline. China Microbiology Market has grown approximately 4 times in 2016 compared to its market value in 2007. China Molecular Testing Market is expected to grow almost five times in future from its present market. Contribution of Point of Care Testing (POCT) market is low compared to Hematology Market, Coagulation Market and Self Monitoring of Blood Glucose (SMBG) Market. Other segments such as Molecular testing, Clinical Chemistry and Microbiology are poised to be remarkable expansion in the near future. Roche is the leading company in the China IVD market.

Factors Driving the Growth of In-Vitro Diagnostics (IVD) in China

Some of the key factors driving the growth of China IVD market are the rising incidences of chronic lifestyle diseases, public health awareness, growing aging population, demand of tests in rural areas stimulated by the healthcare reform plan, increasing demand from the middle class for high–end products and an increase in the number of hospitals and independent clinical laboratories.

China In-Vitro Diagnostics (IVD) Market, Forecast, Companies Analysis, Registration Rules is the 5th edition report on In-Vitro Diagnostics by Renub Research. This presents a detailed account of In-Vitro Diagnostics Market, its 8 Segments Market, Companies In-Vitro Diagnostics Sales in China, Registration of In-Vitro Diagnostics in China.

This 101 Page report with 36 Figures and 2 Tables studies the China IVD market from 6 view points:

Market and Forecast
Segment Wise Market & Forecast
Development Environment & Regulatory Status in China IVD market
Company Wise IVD Sales & Forecast
Growth Drivers for China In-Vitro Diagnostics
Challenges for China In-Vitro Diagnostics

Make an Enquiry of this report @

China IVD Market – Segment Analysis (2007 – 2022)

Clinical Chemistry Market & Forecast
Immunoassay Market & Forecast
Hematology Market & Forecast
Coagulation Market & Forecast
Microbiology Market & Forecast
Molecular Testing Market & Forecast
Self Monitoring of Blood Glucose (SMBG) Market & Forecast
Point of Care Testing (POCT) Market & Forecast

China IVD – Companies Sales Analysis (2011 – 2022)

Roche Diagnostics
Sysmex Corporation
Mindray Medical International Limited
Shanghai Kehua Bio-Engineering Co. Ltd.
Abbott Laboratories

Profiles of Private Clinical Labs and Diagnostic Services Companies in China

– Zhejiang Di’an Diagnostics Technology Co., Ltd
– ADICON Clinical Laboratories
– Guangzhou Kingmed Diagnostics Center Co. Ltd.
– Kindstar Global (Privately held)
– BGI-Shenzhen (Privately held)
– OriGene Technologies (Privately held)

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Contact Us:

Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
Toll Free: 866-997-4948 (US-CANADA)
Follow us on LinkedIn @
Follow us on Blogger @